Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Department of Veterans Affairs relating to "Reproductive Health Services".

HJRES144 is a joint resolution of disapproval under the Congressional Review Act (CRA) targeting a Department of Veterans Affairs (VA) rule on reproductive health services. The resolution states that Congress disapproves the rule and that it "shall have no force or effect." This is a procedural mechanism to overturn an executive branch regulation. It does not appropriate funds, create new market opportunities, or impose new costs on businesses. The resolution's focus is solely on the VA's administrative policy regarding specific healthcare services for veterans. There is no direct money trail associated with this resolution. It does not allocate funding, establish grants, or offer tax credits. The resolution's passage or failure does not alter the VA's overall budget or procurement processes in a way that would benefit or harm specific companies. The VA's existing budget for healthcare services remains unchanged by this resolution, regardless of the outcome. Historically, CRA resolutions of disapproval rarely pass both chambers of Congress and are even less frequently signed into law by the President, particularly when the President is from the same party as the agency issuing the rule. When CRA resolutions have successfully overturned rules, the market impact has been localized to the specific industry directly regulated by the overturned rule. For example, in 2017, Congress used the CRA to overturn an Obama-era rule requiring internet service providers to obtain customer consent before sharing browsing data. This action was seen as a minor positive for telecommunications companies like Verizon ($VZ) and AT&T ($T) as it reduced compliance burdens, but did not result in significant stock price movements. This resolution, however, targets a VA administrative rule with no direct commercial implications for publicly traded companies. No specific companies stand to gain or lose from the passage or failure of HJRES144. The resolution does not affect the business operations, revenue streams, or regulatory environment of any publicly traded entity. The resolution's impact is confined to the administrative policy of the Department of Veterans Affairs regarding specific healthcare services. The next step for HJRES144 is consideration by the House Committee on Veterans' Affairs, to which it was referred. Given the resolution's nature and the current political landscape, its likelihood of becoming law is low. Even if it were to pass both chambers, it would likely face a presidential veto. The timeline for committee action is uncertain, but even if it progresses, the market impact remains neutral.